Abstract
Background The COVID-19 pandemic and response have the potential to disrupt access and use of reproductive, maternal, and newborn health (RMNH) services. Numerous initiatives aim to gauge the indirect impact of COVID-19 on RMNH.
Methods We assessed the impact of COVID-19 on RMNH coverage in the early stages of the pandemic using panel survey data from PMA-Ethiopia. Enrolled pregnant women were surveyed 6-weeks post-birth. We compared the odds of service receipt, coverage of RMNCH service indicators, and health outcomes within the cohort of women who gave birth prior to the pandemic and the COVID-19 affected cohort. We calculated impacts nationally and by urbanicity.
Results This dataset shows little disruption of RMNH services in Ethiopia in the initial months of the pandemic. There were no significant reductions in women seeking health services or the content of services they received for either preventative or curative interventions. In rural areas, a greater proportion of women in the COVID-19 affected cohort sought care for peripartum complications, ANC, PNC, and care for sick newborns. Significant reductions in coverage of BCG vaccination and chlorohexidine use in urban areas were observed in the COVID-19 affected cohort. An increased proportion of women in Addis Ababa reported postpartum family planning in the COVID-19 affected cohort. Despite the lack of evidence of reduced health services, the data suggest increased stillbirths in the COVID-19 affected cohort.
Discussion The government of Ethiopia’s response to control the COVID-19 pandemic and ensure continuity of essential health services appears to have successfully averted most negative impacts on maternal and neonatal care. This analysis cannot address the later effects of the pandemic and may not capture more acute or geographically isolated reductions in coverage. Continued efforts are needed to ensure that essential health services are maintained and even strengthened to prevent indirect loss of life.
What is already known?
COVID-19 pandemic and response have the potential to disrupt access and use of reproductive, maternal, and neonatal health services
Anecdotal evidence suggests some disruptions to health system staffing and resources, service access, and health campaigns in Ethiopia early in the pandemic
What are the new findings?
Our analysis of PMA-Ethiopia panel survey data shows little disruption of RMNH services in Ethiopia in the initial months of the pandemic
Compared to immediately prior to the pandemic we observed an increase in care-seeking in rural areas, commodity-related intervention reductions in urban areas, and an increase in postpartum family planning in Addis Ababa
Despite the lack of evidence of a reduction in health services, the data suggest increased stillbirths in the COVID-19 affected cohort
What do the new findings imply?
The government of Ethiopia successfully maintained continuity of most RMNCH services during the early stages of the COVID-19 pandemic
Continued efforts are needed to ensure that essential health services are maintained and even strengthened to prevent indirect loss of life
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported, in whole, by the Bill and Melinda Gates Foundation [INV 009466]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All procedures were approved by both the Addis Ababa University, College of Health Sciences [075/13/SPH] and Johns Hopkins Bloomberg School of Public Health [00009391] Institutional Review Boards.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data underlying these analyses are publicly available at https://www.pmadata.org/data/available-datasets/request-access-dataset.
https://www.pmadata.org/data/available-datasets/request-access-dataset
